C., Fitzgerald P., Newmeyer D
Some dosage forms listed on this page may not apply specifically to the brand name L-Carnitine
225-227 Importantly, age-related hearing loss has been identified as one of the most modifiable risk factors for dementia
This approach aims to maximize therapeutic benefits while minimizing risks
Points of Interest (so far) in CagriSema Trials: Advanced Trials: Novo's trial is the most advanced for an amylin drug candidate currently being tested in the market
New Psychotic or Manic Symptoms CNS stimulants, at the recommended dosage, may cause psychotic or manic symptoms (e.g., hallucinations, delusional thinking, or mania) in patients without a prior history of psychotic illness or mania